The Goldman Sachs Group Analysts Give MorphoSys (ETR:MOR) a €24.00 Price Target

MorphoSys (ETR:MOR – Get Rating) has been given a €24.00 ($25.81) price target by stock analysts at The Goldman Sachs Group in a research report issued on Friday, Borsen Zeitung reports. The Goldman Sachs Group’s target price points to a potential upside of 15.33% from the company’s current price. Several other brokerages also recently weighed […]

Related Keywords

United States ,Borsen Zeitung ,Berenberg Bank ,Deutsche Bank Rese ,Deutsche Bank Aktiengesellschaft ,Jpmorgan Chase Co ,Morphosys Company Profile Get Rating ,Goldman Sachs Group ,Barclays ,Get Rating ,Bank Aktiengesellschaft ,Bank Rese ,Sys Company Profile ,Morphosys ,Petr Mor ,Humor ,Medical ,Set Price Target ,The Goldman Sachs Group Inc ,